Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:A risk score to predict kidney survival in patients with autosomal recessive polycystic kidney disease at the age of two months
Avtorji:ID Burgmaier, Kathrin (Avtor)
ID Kilian, Samuel (Avtor)
ID Arbeiter, Klaus (Avtor)
ID Atmis, Bahriye (Avtor)
ID Boyer, Olivia (Avtor)
ID Buescher, Anja Katrin (Avtor)
ID Dursun, Ismail (Avtor)
ID Rus, Rina (Sodelavec pri raziskavi), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (2,87 MB)
MD5: 29976BF9EEE67C569538DF254A25275E
 
URL URL - Izvorni URL, za dostop obiščite https://www.kidney-international.org/article/S0085-2538(25)00086-9/fulltext
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Autosomal recessive polycystic kidney disease (ARPKD) is a severe hepatorenal fibrocystic disorder. Its rareness and the variability of disease courses have been major obstacles for the establishment of clinical trials on treatment of kidney disease in ARPKD. In this observational study we characterized kidney disease progression in a very large cohort of up to 658 patients with the clinical diagnosis of ARPKD and identified risk factors associated with rapid kidney disease progression. The estimated probability of kidney failure by the age of 20 years was 50.1% (95% confidence interval 42.2%‒57.0%), with earlier kidney failure in specific subgroups. Mean yearly estimated glomerular filtration rate decline after the first year of life was 1.3 ml/min per 1.73 m2 during childhood and adolescence in the overall cohort, ranging from 0.5 to 2.2 ml/min per 1.73 m2 in various subgroups. Furthermore, we developed prediction models for the relative risk of early kidney failure to be applied at the age of two months in daily clinical life. The finally chosen predictor set for a score based on a Cox model encompassed five factors: gestational age at oligo- or anhydramnios, gestational age at birth, functional genotype, serum creatinine (mg/dl) as well as documentation of arterial hypertension at the age of two months. The derived simple prognostic score showed good prediction performance, especially in the first three years of life. It reliably identified patients who are not at risk of early kidney failure and may be helpful to identify patients at risk of more rapid disease progression that could benefit from novel therapeutic interventions.
Ključne besede:ciliopathies, fibrocystic hepatorenal disease, fibrocystin, kidney survival, polycystic kidney disease
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 903-915
Številčenje:Vol. 107, issue 5
PID:20.500.12556/DiRROS-24122 Novo okno
UDK:616.6
ISSN pri članku:1523-1755
DOI:10.1016/j.kint.2025.01.023 Novo okno
COBISS.SI-ID:238027779 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 3. 6. 2025;
Datum objave v DiRROS:14.11.2025
Število ogledov:170
Število prenosov:64
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Kidney international
Skrajšan naslov:Kidney int.
Založnik:Nature Publishing Group
ISSN:1523-1755
COBISS.SI-ID:2928148 Novo okno

Gradivo je financirano iz projekta

Financer:EC - European Commission
Številka projekta:101080717
Naslov:Therapies for Renal Ciliopathies
Akronim:TheRaCil

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Nazaj